EP1476415A1 - Iodation de 4-fluoro-benzaldehyde - Google Patents
Iodation de 4-fluoro-benzaldehydeInfo
- Publication number
- EP1476415A1 EP1476415A1 EP03742706A EP03742706A EP1476415A1 EP 1476415 A1 EP1476415 A1 EP 1476415A1 EP 03742706 A EP03742706 A EP 03742706A EP 03742706 A EP03742706 A EP 03742706A EP 1476415 A1 EP1476415 A1 EP 1476415A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- fluoro
- benzaldehyde
- inorganic
- iodination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
Definitions
- Potassium channels play an important role in regulating cell membrane excitability.
- Such diseases or conditions include asthma, epilepsy, male sexual dysfunction, female sexual dysfunction, pain, bladder overactivity, stroke, diseases associated with decreased skeletal blood flow such as Raynaud's phenomenon and intermittent claudication, eating disorders, functional bowel disorders, neurodegeneration, benign prostatic hyperplasia (BPH), dysmenorrhea, premature labor, alopecia, cardioprotection, coronary artery disease, angina, ischemia, and incontinence.
- diseases or conditions include asthma, epilepsy, male sexual dysfunction, female sexual dysfunction, pain, bladder overactivity, stroke, diseases associated with decreased skeletal blood flow such as Raynaud's phenomenon and intermittent claudication, eating disorders, functional bowel disorders, neurodegeneration, benign prostatic hyperplasia (BPH), dysmenorrhea, premature labor, alopecia, cardioprotection, coronary artery disease, angina, ischemia, and incontinence.
- BPH benign prostatic hyperplasia
- dysmenorrhea premature labor
- alopecia
- 4-fluoro-3-iodo-benzaldehyde was previously synthesized in five steps as shown in Scheme 1.
- 4-fluorobenzoic acid (1) is converted to 4-fluoro-3-nitrobenzoic acid (2) which is then reduced to the corresponding amine (3). Further reduction results in the alcohol (4) and subsequent iodination (5) and oxidation ultimately leads to the iodinated benzaldehyde (6).
- the present invention relates to a process for producing an intermediate that is used to make a dihydropyridine potassium channel opener.
- the present invention relates to an efficient synthesis of 4-fluoro-3-iodo-benzaldehyde by iodinating 4-fluoro-benzaldehyde.
- 4-Fluoro-3-iodo-benzaldehyde is a key intermediate in the manufacture of the potassium channel opener, 5-(4-fluoro-3-iodophenyl)-5,10 dihydro-lH,3H- dipyrano[3,4-b:4,3-e]pyridine-4,6(7H,9H) dione.
- the present invention relates to an improved process for iodinating benzaldehydes.
- the improved process allows for a one- step procedure for synthesizing 4- fluoro-3-iodo-benzaldehyde.
- 4-Fluoro-3-iodobenzaldehyde is synthesized by combining 4- fluorobenzaldehyde and N-iodosuccinimide in an acid medium.
- the 4-Fluoro-3- iodobenzaldehyde and N-iodosuccinimide are in a 1 : 1.2 equivalents ratio respectively.
- Suitable acids for use in the present invention include organic acids and inorganic acids.
- An example of organic acids suitable for use in the present invention includes, but is not intended to be limited to, trifluoromethanesulfonic acid.
- Inorganic acids are suitable for use in the present invention as well.
- Inorganic acids suitable for use in the present invention include, but is not intended to be limited to, nitric acid, sulfuric acid, and hydrochloride acid.
- the inorganic acid may be used in combination with acetic acid as well.
- Acetic acid is used for solubility purposes.
- a strong inorganic acid/acetic acid combination is suitable for use in the present invention.
- the inorganic acid/acetic acid combination is in a 1:1 ratio.
- the wetcake was dissolved in 380 g ethyl acetate / heptane (1:1 v/v containing 250 ppm BHT) and the solution was washed with 10% aqueous sodium thiosulfate (204 g), then with 10% aqueous sodium carbonate (214 g), followed by 200 g water.
- the solution was concentrated to approximately 40 mL, and 148 g heptane (containing
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
L'invention concerne un procédé amélioré d'iodation d'un benzaldéhyde substitué.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7861702A | 2002-02-19 | 2002-02-19 | |
US78617 | 2002-02-19 | ||
PCT/US2003/003082 WO2003070678A1 (fr) | 2002-02-19 | 2003-02-03 | Iodation de 4-fluoro-benzaldehyde |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1476415A1 true EP1476415A1 (fr) | 2004-11-17 |
Family
ID=27752716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03742706A Withdrawn EP1476415A1 (fr) | 2002-02-19 | 2003-02-03 | Iodation de 4-fluoro-benzaldehyde |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1476415A1 (fr) |
JP (1) | JP2005525350A (fr) |
CA (1) | CA2476824A1 (fr) |
MX (1) | MXPA04008072A (fr) |
WO (1) | WO2003070678A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008143141A1 (fr) * | 2007-05-18 | 2008-11-27 | Nippoh Chemicals Co., Ltd. | Procédé de fabrication d'un composé aromatique halogéné |
JP5295613B2 (ja) * | 2008-04-07 | 2013-09-18 | 日宝化学株式会社 | ヨウ素化芳香族化合物の製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1040097B1 (fr) * | 1997-12-18 | 2004-04-14 | Abbott Laboratories | Composes ouvrant les canaux potassium |
-
2003
- 2003-02-03 MX MXPA04008072A patent/MXPA04008072A/es unknown
- 2003-02-03 CA CA002476824A patent/CA2476824A1/fr not_active Abandoned
- 2003-02-03 JP JP2003569588A patent/JP2005525350A/ja not_active Withdrawn
- 2003-02-03 WO PCT/US2003/003082 patent/WO2003070678A1/fr not_active Application Discontinuation
- 2003-02-03 EP EP03742706A patent/EP1476415A1/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO03070678A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003070678A1 (fr) | 2003-08-28 |
CA2476824A1 (fr) | 2003-08-28 |
MXPA04008072A (es) | 2004-11-26 |
JP2005525350A (ja) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0249797A (ja) | エリスロマイシンaオキシム及びその塩の製造方法 | |
CN110330500B (zh) | 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法 | |
Stevens et al. | Camphorae: chiral intermediates for the enantiospecific total synthesis of steroids. 1 | |
JP2003513084A (ja) | 5−カルボキシフタリドの製造方法 | |
JP4559730B2 (ja) | 14−ヒドロキシノルモルフィノン誘導体の調製方法。 | |
EP1476415A1 (fr) | Iodation de 4-fluoro-benzaldehyde | |
Blair et al. | Lactones. Part II. The structure of mellein | |
US20030220526A1 (en) | Iodination of 4-fluoro-benzaldehyde | |
JP5270091B2 (ja) | 7−アルキル−10−ヒドロキシ−20(s)−カンプトテシンを調製するためのプロセス | |
JP2001233870A (ja) | 3−(1−ヒドロキシ−ペンチリデン)−5−ニトロ−3h−ベンゾフラン−2−オン、その製造方法及びその用途 | |
JP4954421B2 (ja) | クラブラン酸塩の精製方法 | |
JP2888814B2 (ja) | ベンゾフェノン誘導体の調製方法 | |
CN112409434A (zh) | 一种去氢孕酮的合成方法 | |
CN112679326A (zh) | 一种3,4-二甲氧基苯甲醛的制备方法 | |
JPH0578277A (ja) | 3,3,3−トリフルオロ乳酸の製造方法及び光学純度の向上法 | |
CN109081841A (zh) | 一种佐匹克隆中间体的制备方法 | |
JPS6344733B2 (fr) | ||
Liu et al. | Oxidative deamination of benzylic amines induced by phenyl dichlorophosphate | |
JPH0641012A (ja) | 光学活性3−フェニル−3−ヒドロキシプロピオン酸エステルの製造方法 | |
US4169940A (en) | Chemical oxidation of novobiocin and products obtained therefrom | |
CH634071A5 (en) | Therapeutically active pyranoquinolones | |
EP0611232A1 (fr) | Procédé pour la préparatiuon de dérivés phénylbenzamides | |
JP2005523916A (ja) | ヒペルフォリンのハロゲン化誘導体、それらの使用、およびそれらを含む製剤 | |
HU195659B (en) | Process for producing cotarnine | |
HU178970B (en) | Process for preparing lower alkyl esters of 4,10-dihydro-10-oxo-thieno/3,2-c/ /1/ benzoxepin-8-acetic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040812 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060901 |